Methods and compositions for immune protection against extra-intestinal pathogenic E. coli
US-10583185-B2 · Mar 10, 2020 · US
This page is not indexed by search engines while we improve data quality.
Glaxosmithkline Biological S A patents
Glaxosmithkline Biological S A holds 3 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 3 |
| Recent patents | 0 |
| First publication | May 14, 2019 |
| Latest publication | Mar 10, 2020 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Process for producing influenza vaccine
US-10398771-B2 · Sep 3, 2019 · US
Methods and compositions relating to CRM197
US-10287330-B2 · May 14, 2019 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Methods and compositions for immune protection against extra-intestinal pathogenic E. coli
US-10583185-B2 · Mar 10, 2020 · US
Process for producing influenza vaccine
US-10398771-B2 · Sep 3, 2019 · US
Methods and compositions relating to CRM197
US-10287330-B2 · May 14, 2019 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 3 |
| Human Necessities | 2 |
| Cross-Sectional Technologies | 1 |